Soleus Capital Management »

Miragen Therapeutics shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 138k 21.78
2023-06-30 $809k 34k 23.79
2022-09-30 $400k 20k 20.49
2022-06-30 $9.7M 841k 11.57
2022-03-31 $1.7M 90k 18.49
2021-12-31 $1.8M 90k 19.77
2021-03-31 $1.1M 68k 16.71